Clinical Trials Browser

Terminated × INDUSTRY × Adrenocortical Carcinoma × Clear all

Paraganglioma, Pheochromocytoma, Adrenocortical Carcinoma

NCT03746431 2026-01-07

A Phase 1 Study of [225Ac]-FPI-1434 Injection

BreastDermatologicEndocrineGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Breast Neoplasms, Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Adrenocortical Carcinoma, Triple Negative Breast Neoplasms

NCT05999292 2024-12-09

Phase 1 Study of 68Ga-R8760

Phase 1 Terminated

11 enrolled

Endocrine

Adrenocortical Carcinoma

NCT03145909 2018-11-29

A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)

Phase 1 Terminated

19 enrolled

BreastEndocrineGastrointestinalGenitourinary

Breast Neoplasms, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms, Adrenocortical Carcinoma

NCT01832974 2015-04-27

Possible New Therapy for Advanced Cancer

Phase 1 Terminated

9 enrolled

Endocrine

Adrenal Gland Neoplasms, Neoplasm Metastasis, Adrenocortical Carcinoma

Clinical Trials

Spencer

A Phase 1 Study of [225Ac]-FPI-1434 Injection

Phase 1 Study of 68Ga-R8760

A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)

Possible New Therapy for Advanced Cancer